We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NPCE market cap is 379.53M. The company's latest EPS is USD -1.1627 and P/E is -11.71.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.16M | 12.79M | 14.47M | 16.51M | 16.43M |
| Operating Income | -10.2M | -9.86M | -8.32M | -7.85M | -5.95M |
| Net Income | -11.79M | -11.15M | -10.38M | -9.12M | -7.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36.97M | 41.14M | 45.18M | 45.52M | 65.42M |
| Operating Income | -22.03M | -13.05M | -23.74M | -40.79M | -27.17M |
| Net Income | -29.97M | -24.28M | -36.08M | -47.08M | -32.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 120.47M | 114.11M | 106.27M | 102.23M | 99.3M |
| Total Liabilities | 77.07M | 79.33M | 78.78M | 81.01M | 82.94M |
| Total Equity | 43.41M | 34.78M | 27.49M | 21.23M | 16.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.1M | 55.95M | 133.56M | 114.11M | 107.65M |
| Total Liabilities | 76.88M | 62.36M | 60.06M | 79.33M | 87M |
| Total Equity | -129.35M | -147.83M | 73.5M | 34.78M | 20.65M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.03M | -36.87M | -9.7M | -14.06M | -16.36M |
| Investing | 14.9M | 23.8M | 10.07M | 15.37M | 19.56M |
| Financing | 628k | 490k | -255k | -60k | -87k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.03M | -21.61M | -24.58M | -36.87M | -19.7M |
| Investing | 3.62M | -10.77M | -85.4M | 23.8M | 23.03M |
| Financing | 21.37M | 55.01M | 102.53M | 490k | 8.13M |
| Market Cap | 379.53M |
| Price to Earnings Ratio | -11.71 |
| Price to Sales Ratio | 5.9 |
| Price to Cash Ratio | 21.38 |
| Price to Book Ratio | 18.69 |
| Dividend Yield | - |
| Shares Outstanding | 28.34M |
| Average Volume (1 week) | 98.87k |
| Average Volume (1 Month) | 124.8k |
| 52 Week Change | 172.71% |
| 52 Week High | 18.15 |
| 52 Week Low | 3.80 |
| Spread (Intraday) | 1.13 (7.91%) |
| Company Name | Neuropace Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.neuropace.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
